Should You Buy Intuitive Surgical Stock Before July 16 Earnings?

Intuitive Surgical (ISRG), the leader in robotic-assisted surgery, is scheduled to report its second-quarter 2026 earnings on July 16. The company has surpassed analyst expectations for four consecutive quarters, prompting investors to wonder if it can achieve a fifth consecutive beat.

Rating Change

No official analyst rating change has been issued for ISRG recently. However, attention is focused on whether the company can continue its earnings surprise streak.

Analyst Rationale

Analysts highlight Intuitive Surgical's ability to exceed expectations due to strong demand for its da Vinci surgical systems and an increasing number of surgical procedures. Improved profit margins and a growing customer base also support optimism.

Context

ISRG stock is trading at elevated levels, with a valuation reflecting future growth expectations. Compared to competitors like Medtronic (MDT) and Johnson & Johnson (JNJ), Intuitive maintains a strong competitive edge in the robotic surgery market. Additionally, NVIDIA's (NVDA) performance may influence sentiment in the broader tech sector.

What to Make of It

The future performance of ISRG stock hinges on its ability to meet earnings expectations. Investors are eagerly awaiting the July 16 announcement to see if the streak of positive surprises continues.